Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 
Artelo Biosciences and University of Western Ontario Awarded Research Grant by Mitacs
Mitacs Accelerate grant expected to fund 50% of research costs evaluating ART26.12 as a potential treatment for anxiety disorders LA...
Grey Cloak Tech Inc. Announces New Sales and Marketing Medical Advisory Board
In continuing efforts to expand on its sales and marketing efforts, Grey Cloak Tech announces Dr. James Rouse as president...
Premier Health Announces the Appointment of Sylvain Charbonneau as its New CFO
MONTREAL, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (formerly known as Physinorth Acquisition Corporation Inc.) (TSXV:...
Generex and NuGenerex Immuno-Oncology Ii-Key-SARS-CoV-2 Vaccine Partner Bintai Kinden Executes its Exclusive Distribution & Licensing Option for Australia and New Zealand
Memorandum of Understanding (MOU) signed by both parties Negotiating final contract terms Upfront payment on closing Licensing fees, expenses, and...
180 Life Sciences Corp. Continues to Expand Intellectual Property Portfolio With Additional Patent Grants
MENLO PARK, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF or the "Company"), a clinical-stage biotechnology company...
SmileDirectClub Partners With MetLife
Telehealth Pioneer and Leading Dental Insurer Team Up to Expand Consumer Access to Safe, Convenient and Affordable Premium Teeth Straightening...
ALRT Diabetes Solution Platform is Cleared by Health Canada
The ALRT Diabetes Solution software received Medical Device Establishment Licence (MDEL) – MDEL 15143 (Company ID 161989) RICHMOND, Va., Nov....
PMV Pharma Doses First Patient in Phase 1/2 Study of PC14586, a First-in-Class Precision Oncology Therapy That Targets Mutant p53
PC14586 targets p53 Y220C mutants to selectively reactivate p53, restoring the protein’s tumor-suppressing function Phase 1/2 study is enrolling patients...
DLH to Announce Fourth Quarter FY20 Financial Results
ATLANTA, Nov. 23, 2020 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and...
TRACON Announces Publication in Cancer Cell of Clinical Data that Provides Molecular Insight into the Mechanism of Action of TRC102 and Patient Populations Most Likely to Respond to Treatment
SAN DIEGO, Nov. 23, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development...
Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million
TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a...
Kiniksa Announces U.S. FDA Acceptance of sBLA and Priority Review for Rilonacept in Recurrent Pericarditis
- PDUFA goal date of March 21, 2021 -- Filing based on positive data from RHAPSODY, which achieved its primary and...
HTG Announces One-for-Fifteen Reverse Stock Split
TUCSON, Ariz., Nov. 23, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission...
Kymera Therapeutics to Present at the Piper Sandler 32nd Annual Healthcare Conference
WATERTOWN, Mass., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and...
Next-generation Ultrasound System, the SONIMAGE HS2, Delivers Advanced Features for Precision Diagnosis and Interventions
SONIMAGE HS2 Compact Ultrasound System The new SONIMAGE® HS2 Compact Ultrasound System from Konica Minolta Healthcare. WAYNE, N.J., Nov. 23,...
Baudax Bio Announces $12 Million Offering Priced at a Premium to Market
MALVERN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute...
Onconova Therapeutics Files Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
U.S. Phase 1 trial patient enrollment to begin in the first half of 2021 China Phase 1 trial enrollment ongoing...
Teneobio Announces Poseida’s Exercise of Four Commercial License Options for UniDabs to Targets for Advanced CAR T-cell Therapies
NEWARK, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Teneobio, Inc., a clinical stage next generation, multi-specific antibody therapeutics company, announced...
Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients
Studies reinforce clonoSEQ as standard of care in minimal residual disease (MRD) across eight disease states Real-world evidence shows treatment...
Neoleukin Therapeutics Announces Participation in Piper Sandler 32nd Annual Virtual Healthcare Conference
SEATTLE, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...